User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 3 results.
    • Journal article
    Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study.
    Ajani, Jaffer El Hajbi, Farid Cunningham, David Alsina, Maria Thuss-Patience, Peter Scagliotti, Giorgio V Van den Eynde, Marc[UCL] Kim, Sung-Bae Kato, Ken Shen, Lin Li, Liyun Ding, Ningning Shi, Jingwen Barnes, Gisoo Van Cutsem, Eric (2024) ESMO open — Vol. 9, no.1, p. 102202 [1-9] (2024)
    • Journal article
    Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.
    Fuchs, Charles S Shitara, Kohei Di Bartolomeo, Maria Lonardi, Sara Al-Batran, Salah-Eddin Van Cutsem, Eric Ilson, David H Alsina, Maria Chau, Ian Lacy, Jill Ducreux, Michel Mendez, Guillermo Ariel Alavez, Alejandro Molina Takahari, Daisuke Mansoor, Wasat Enzinger, Peter C Gorbounova, Vera Wainberg, Zev A Hegewisch-Becker, Susanna Ferry, David Lin, Ji Carlesi, Roberto Das, Mayukh Shah, Manish A RAINFALL Study Group Van den Eynde, Marc[UCL] (2019) The Lancet. Oncology — , p. [1-16] (2019)
    • Journal article
    Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.
    Mansoor, Wasat Arkenau, Hendrik-Tobias Alsina, Maria Shitara, Kohei Thuss-Patience, Peter Cuffe, Sinead Dvorkin, Mikhail Park, David Ando, Takayuki Van den Eynde, Marc[UCL] Beretta, Giordano D Zaniboni, Alberto Doi, Toshihiko Tabernero, Josep Ilson, David H Makris, Lukas Benhadji, Karim A Van Cutsem, Eric (2021) Gastric cancer — Vol. 24, no. 4, p. 970-977 (2021)